Orta lob sendromu sağ akciğer orta lobunun kronik veya tekrarlayan atelektazileri ile karakterize bir klinik tablodur. Orta lob sendromunun fizyopatolojik olarak obstrüktif ve obstrüktif olmayan şeklinde iki formu vardır. Obstrüktif orta lob sendromuna genellikle orta lob bronşundaki endobronşiyal lezyonlar veya orta lob bronşuna dıştan bası neden olmaktadır. Obstrüktif olmayan tipinde ise bronkoskopide veya bilgisayarlı toraks tomografisinde orta lob bronşunda obstrüksiyona ait bulgu yoktur. Obstrüktif olmayan orta lob sendromu hastaları bronkodilatörler, mukolitik ilaçlar ve antibiyotikler ile yapılan medikal tedaviye genellikle yanıt vermektedir. Atelektaziye yönelik uygulanan yoğun medikal tedavinin yetersiz olduğu veya bronşektazi olduğunda cerrahi rezeksiyon endikasyonu vardır. Lobektomi bu hastalarda etkin ve güvenilir bir tedavi şeklidir.
Middle lobe syndrome is a clinical entity characterized by chronic or recurrent atelectasis of the right middle lung lobe. Pathophysiologically, there are two forms of middle lobe syndrome, namely obstructive and nonobstructive. Obstructive middle lobe syndrome is usually caused by endobronchial lesions or extrinsic compression of the middle lobe bronchus. In the non-obstructive type, no obstruction of the middle lobe bronchus is evident during bronchoscopy or with computed tomography of the thorax. Patients with non-obstructive middle lobe syndrome usually respond to medical therapy with bronchodilators, mucolytic agents, and antibiotics. Surgical resection is indicated for bronchiectasis or failure of intensive medical therapy to resolve the atelectasis. Lobectomy is an efficient and safe therapy modality in these patients ">
[PDF] Orta lob sendromu | [PDF] The middle lobe syndrome
Orta lob sendromu sağ akciğer orta lobunun kronik veya tekrarlayan atelektazileri ile karakterize bir klinik tablodur. Orta lob sendromunun fizyopatolojik olarak obstrüktif ve obstrüktif olmayan şeklinde iki formu vardır. Obstrüktif orta lob sendromuna genellikle orta lob bronşundaki endobronşiyal lezyonlar veya orta lob bronşuna dıştan bası neden olmaktadır. Obstrüktif olmayan tipinde ise bronkoskopide veya bilgisayarlı toraks tomografisinde orta lob bronşunda obstrüksiyona ait bulgu yoktur. Obstrüktif olmayan orta lob sendromu hastaları bronkodilatörler, mukolitik ilaçlar ve antibiyotikler ile yapılan medikal tedaviye genellikle yanıt vermektedir. Atelektaziye yönelik uygulanan yoğun medikal tedavinin yetersiz olduğu veya bronşektazi olduğunda cerrahi rezeksiyon endikasyonu vardır. Lobektomi bu hastalarda etkin ve güvenilir bir tedavi şeklidir. ">
Orta lob sendromu sağ akciğer orta lobunun kronik veya tekrarlayan atelektazileri ile karakterize bir klinik tablodur. Orta lob sendromunun fizyopatolojik olarak obstrüktif ve obstrüktif olmayan şeklinde iki formu vardır. Obstrüktif orta lob sendromuna genellikle orta lob bronşundaki endobronşiyal lezyonlar veya orta lob bronşuna dıştan bası neden olmaktadır. Obstrüktif olmayan tipinde ise bronkoskopide veya bilgisayarlı toraks tomografisinde orta lob bronşunda obstrüksiyona ait bulgu yoktur. Obstrüktif olmayan orta lob sendromu hastaları bronkodilatörler, mukolitik ilaçlar ve antibiyotikler ile yapılan medikal tedaviye genellikle yanıt vermektedir. Atelektaziye yönelik uygulanan yoğun medikal tedavinin yetersiz olduğu veya bronşektazi olduğunda cerrahi rezeksiyon endikasyonu vardır. Lobektomi bu hastalarda etkin ve güvenilir bir tedavi şeklidir.
Middle lobe syndrome is a clinical entity characterized by chronic or recurrent atelectasis of the right middle lung lobe. Pathophysiologically, there are two forms of middle lobe syndrome, namely obstructive and nonobstructive. Obstructive middle lobe syndrome is usually caused by endobronchial lesions or extrinsic compression of the middle lobe bronchus. In the non-obstructive type, no obstruction of the middle lobe bronchus is evident during bronchoscopy or with computed tomography of the thorax. Patients with non-obstructive middle lobe syndrome usually respond to medical therapy with bronchodilators, mucolytic agents, and antibiotics. Surgical resection is indicated for bronchiectasis or failure of intensive medical therapy to resolve the atelectasis. Lobectomy is an efficient and safe therapy modality in these patients ">
Orta lob sendromu sağ akciğer orta lobunun kronik veya tekrarlayan atelektazileri ile karakterize bir klinik tablodur. Orta lob sendromunun fizyopatolojik olarak obstrüktif ve obstrüktif olmayan şeklinde iki formu vardır. Obstrüktif orta lob sendromuna genellikle orta lob bronşundaki endobronşiyal lezyonlar veya orta lob bronşuna dıştan bası neden olmaktadır. Obstrüktif olmayan tipinde ise bronkoskopide veya bilgisayarlı toraks tomografisinde orta lob bronşunda obstrüksiyona ait bulgu yoktur. Obstrüktif olmayan orta lob sendromu hastaları bronkodilatörler, mukolitik ilaçlar ve antibiyotikler ile yapılan medikal tedaviye genellikle yanıt vermektedir. Atelektaziye yönelik uygulanan yoğun medikal tedavinin yetersiz olduğu veya bronşektazi olduğunda cerrahi rezeksiyon endikasyonu vardır. Lobektomi bu hastalarda etkin ve güvenilir bir tedavi şeklidir.
The middle lobe syndrome
Middle lobe syndrome is a clinical entity characterized by chronic or recurrent atelectasis of the right middle lung lobe. Pathophysiologically, there are two forms of middle lobe syndrome, namely obstructive and nonobstructive. Obstructive middle lobe syndrome is usually caused by endobronchial lesions or extrinsic compression of the middle lobe bronchus. In the non-obstructive type, no obstruction of the middle lobe bronchus is evident during bronchoscopy or with computed tomography of the thorax. Patients with non-obstructive middle lobe syndrome usually respond to medical therapy with bronchodilators, mucolytic agents, and antibiotics. Surgical resection is indicated for bronchiectasis or failure of intensive medical therapy to resolve the atelectasis. Lobectomy is an efficient and safe therapy modality in these patients
Gudbjartsson T, Gudmundsson G. Middle lobe syndrome: a review of clinicopathological features, diagnosis and treatment. Respiration 2012;84:80-6.
Graham EA, Burford TH, Mayer JH. Middle lobe syndrome. Postgrad Med 1948;4:29-34.
Brock RC, Cann RJ, Dickinson JR. Tuberculous mediastinal lymphadenitis in childhood; secondary effects on the lungs. Guy's Hosp Rep 1937;87:295-317.
Culiner MM. The right middle lobe syndrome, a non- obstructive complex. Dis Chest 1966;50:57-66.
Wagner RB, Johnston MR. Middle lobe syndrome. Ann Thorac Surg 1983;35:679-86.
Ayed AK. Resection of the right middle lobe and lingula in children for middle lobe/lingula syndrome. Chest 2004;125:38-42.
Dees SC, Spock A. Right middle lobe syndrome in children. JAMA 1966;197:8-14.
Bertelsen S, Struve-Christensen E, Aasted A, Sparup J. Isolated middle lobe atelectasis: aetiology, pathogenesis, and treatment of the so-called middle lobe syndrome. Thorax 1980;35:449-52.
Einarsson JT, Einarsson JG, Isaksson H, Gudbjartsson T, Gudmundsson G. Middle lobe syndrome: a nationwide study on clinicopathological features and surgical treatment. Clin Respir J 2009;3:77-81.
Romagnoli V, Priftis KN, de Benedictis FM. Middle lobe syndrome in children today. Paediatr Respir Rev 2014;15:188-93.
Bradham RR, Sealy WC, Young WG Jr. Chronic middle lobe infection. Factors responsible for its development. Ann Thorac Surg 1966;2:612-6.
Kala J, Sahay S, Shah A. Bronchial anthracofibrosis and tuberculosis presenting as a middle lobe syndrome. Prim Care Respir J 2008;17:51-5.
Kim HC, Kim HS, Lee SJ, Jeong YY, Jeon KN, Lee JD, et al. Endobronchial tuberculosis presenting as right middle lobe syndrome: clinical characteristics and bronchoscopic findings in 22 cases. Yonsei Med J 2008;49:615-9.
Kinzy JD, Powers WP, Baddour LM. Case report: Blastomyces dermatitidis as a cause of middle lobe syndrome. Am J Med Sci 1996;312:191-3.
Lambert GW, Baddour LM. Right middle lobe syndrome caused by Mycobacterium fortuitum in a patient with human immunodeficiency virus infection. South Med J 1992;85:767-9.
Livingston GL, Holinger LD, Luck SR. Right middle lobe syndrome in children. Int J Pediatr Otorhinolaryngol 1987;13:11-23.
Oshima M, Maeda H, Furonaka O, Doi M, Nishizaka T, Kuwabara M. Sarcoidosis with multiple organ involvement emerging as Löfgren's syndrome. Intern Med 2003;42:534-7.
Chen HA, Lai SL, Kwang WK, Liu JC, Chen CH, Huang DF. Middle lobe syndrome as the pulmonary manifestation of primary Sjögren's syndrome. Med J Aust 2006;184:294-5.
Chien HP, Lin TP, Chen HL, Huang TW. Right middle lobe atelectasis associated with endobronchial silicotic lesions. Arch Pathol Lab Med 2000;124:1619-22.
Illamperuma C, Reid J, Kanthan R. [Article in English, French] Chyloptysis with right middle lobe syndrome complicated postoperatively by chylothorax: an unusual cause of right middle lobe syndrome. Can Respir J 2009;16:1-2.
Gudmundsson G, Gross TJ. Middle lobe syndrome. Am Fam Physician 1996;53:2547-50.
Springer C, Avital A, Noviski N, Maayan C, Ariel I, Mogel P, et al. Role of infection in the middle lobe syndrome in asthma. Arch Dis Child 1992;67:592-4.
Thacher H, Kaplan A. Middle lobe syndrome in asthmatic children. J Maine Med Assoc 1972;63:46-8.
Berrocal T, Madrid C, Novo S, Gutiérrez J, Arjonilla A, Gómez-León N. Congenital anomalies of the tracheobronchial tree, lung, and mediastinum: embryology, radiology, and pathology. Radiographics 2004;24:17.
Emre JC, Aksoy U, Baysak A, Oz AT, Borand H, Bacakoglu F. Kartagener's syndrome and primary ciliary dyskinesia: two cases in siblings. Respir Case Rep 2014;3:56-9.
Shields TW, LoCicero III J, Reed CE, Feins RH, editors. General Thoracic Surgery. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 1125-6.
Meteroglu F, Sahin A, Eren TS. Middle lobe syndrome: a retrospective analysis. Turk Gogus Kalp Dama 2012;21:718-22.
McElvein RB, Mayo P. Middle lobe disease. South Med J 1967;60:1029-32.
Inners CR, Terry PB, Traystman RJ, Menkes HA. Collateral ventilation and the middle lobe syndrome. Am Rev Respir Dis 1978;118:305-10.
Rosenbloom SA, Ravin CE, Putman CE, Sealy WC, Vock P, Clark TJ, et al. Peripheral middle lobe syndrome. Radiology 1983;149:17-21.
Javidan-Nejad C, Bhalla S. Bronchiectasis. Radiol Clin North Am 2009;47:289-306.
Fraioli F, Serra G, Ciarlo G, Massaccesi V, Liberali S, Fiorelli A, et al. Chest MR imaging in the follow-up of pulmonary alterations in paediatric patients with middle lobe syndrome: comparison with chest X-ray. Radiol Med 2013;118:444-55.
Rock MJ. The diagnostic utility of bronchoalveolar lavage in immunocompetent children with unexplained infiltrates on chest radiograph. Pediatrics 1995;95:373-7.
Priftis KN, Anthracopoulos MB, Mermiri D, Papadopoulou A, Xepapadaki P, Tsakanika C, et al. Bronchial hyperresponsiveness, atopy, and bronchoalveolar lavage eosinophils in persistent middle lobe syndrome. Pediatr Pulmonol 2006;41:805-11.
Kwon KY, Myers JL, Swensen SJ, Colby TV. Middle lobe syndrome: a clinicopathological study of 21 patients. Hum Pathol 1995;26:302-7.
Eskenasy A, Eana-Iorgulescu L. Pathology of the middle lobe syndromes. A histopathological and pathogenetic analysis of sixty surgically-cured cases. Med Interne 1982;20:73-80.
Redding GJ. Bronchiectasis in children. Pediatr Clin North Am 2009;56:157-71.
Daviskas E, Rubin BK. Effect of inhaled dry powder mannitol on mucus and its clearance. Expert Rev Respir Med 2013;7:65-75.
Kellett F, Redfern J, Niven RM. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respir Med 2005;99:27-31.
Midulla F, Guidi R, Barbato A, Capocaccia P, Forenza N, Marseglia G, et al. Foreign body aspiration in children. Pediatr Int 2005;47:663-8.
Wohlauer MV, Moore EE, Haenel JB, Burlew CC, Barnett CC Jr. Selective Intrabronchial Air Insufflation for Acute Lobar Collapse in the Surgical Intensive Care Unit. J Surg Radiol 2011;2:178-180.
Erelel M, Yakar F, Yakar A. Endobronchial tuberculosis with lobar obstruction successfully treated by argon plasma coagulation. South Med J 2009;102:1078-81.
Doğan R, Alp M, Kaya S, Ayrancioğlu K, Taştepe I, Unlü M, et al. Surgical treatment of bronchiectasis: a collective review of 487 cases. Thorac Cardiovasc Surg 1989;37:183-6.
Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K. American College of Chest Physicians. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd ed). Chest 2007;132(Suppl 3):234S-42S.
Alpay L, Ocakcıoğlu İ, Doğruyol T, Baysungur V, Yalçınkaya İ. Orta lob yerleşimli endobronşial adenoid kistik karsinom olgusuna bronşial sleeve rezeksiyon ile parankim koruyucu cerrahi. Turk Gogus Kalp Dama 2014;22:205-6.
Öz N, Kargı AB, Tütüncü B, Sarper A. Bronş rüptüründe nadir yerleşim yeri: Orta lob bronşu. Turk Gogus Kalp Dama 2013;21:212-5.
Sehitogullari A, Sayir F, Cobanoglu U, Bilici S. Surgical treatment of right middle lobe syndrome in children. Ann Thorac Med 2012;7:8-11.
Seitz G, Warmann SW, Szavay PO, Schellinger K, Schäfer JF, Baden W, et al. Thoracoscopic lobectomy as a treatment option for persistent middle lobe syndrome in children. Pediatr Int 2010;52:79-81.